ArticleCancer immunology, immunotherapy : CII2021

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.

Alexandra Leary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.